Xconomy Seattle

Veratect Secures $4.2M Debt

Luke Timmerman10/6/09

Veratect, the Kirkland, WA-based company that tracks emerging health threats like swine flu, has raised $4.2 million out of $5 million debt financing, according to an amended regulatory filing today. The filing doesn’t say who invested, but the company’s list of directors includes William Savoy, the former manager of billionaire Paul Allen’s Vulcan investment portfolio and Lee Huntsman, the executive director of the Washington Life Sciences Discovery Fund. A spokesperson for the company didn’t immediately respond to a request for comment.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.